PJP:NYE-Invesco Dynamic Pharmaceuticals ETF (USD)

ETF | Health |

Last Closing

USD 83.76

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

ETFs Containing PJP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.07% 90% A- 58% F
Dividend Return 0.76% 56% F 10% F
Total Return 10.83% 95% A 52% F
Trailing 12 Months  
Capital Gain 19.73% 67% D+ 63% D
Dividend Return 1.10% 56% F 12% F
Total Return 20.83% 67% D+ 58% F
Trailing 5 Years  
Capital Gain 35.71% 62% D 64% D
Dividend Return 5.60% 61% D- 14% F
Total Return 41.31% 62% D 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.96% 76% C+ 58% F
Dividend Return 7.53% 71% C- 53% F
Total Return 0.57% 58% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 13.21% 76% C+ 71% C-
Risk Adjusted Return 56.99% 86% B+ 73% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike